Results for tag: "Tegrital"

Tegrital is a brand of central nervous system (CNS) drugs developed by Novartis. It is used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and schizophrenia. Tegrital works by blocking certain receptors in the brain, which helps to reduce the symptoms of these disorders. It is available in both immediate-release and extended-release formulations. Tegrital is one of many CNS drugs on the market, and is often prescribed alongside other medications. It is generally well-tolerated, with few side effects. However, it can cause drowsiness, dizziness, and blurred vision in some patients. Some of the companies in the Tegrital market include Novartis, Pfizer, GlaxoSmithKline, and Johnson & Johnson. These companies produce a variety of CNS drugs, including Tegrital, and are responsible for the research, development, and marketing of these medications. Show Less Read more